Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Morten Orebo Holmström; Guy W Novotny; Jesper Petersen; Mia Aaboe-Jørgensen; Hans Carl Hasselbalch; Mads H Andersen; Signe Ledou Nielsen; Daniel El Fassi; Claudia Schöllkopf

doi:10.1080/10428194.2019.1633634

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Morten Orebo Holmström, Guy W Novotny, Jesper Petersen, Mia Aaboe-Jørgensen, Hans Carl Hasselbalch, Mads H Andersen, Signe Ledou Nielsen, Daniel El Fassi, Claudia Schöllkopf

2 Citations (Scopus)

Original language	English
Journal	Leukemia and Lymphoma
Volume	60
Issue number	13
Pages (from-to)	3296-3299
Number of pages	4
ISSN	1042-8194
DOIs	https://doi.org/10.1080/10428194.2019.1633634
Publication status	Published - 1 Jul 2019

Access to Document

10.1080/10428194.2019.1633634

Cite this

Holmström, M. O., Novotny, G. W., Petersen, J., Aaboe-Jørgensen, M., Hasselbalch, H. C., Andersen, M. H., Nielsen, S. L., Fassi, D. E., & Schöllkopf, C. (2019). Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy. Leukemia and Lymphoma, 60(13), 3296-3299. https://doi.org/10.1080/10428194.2019.1633634

Holmström, MO , Novotny, GW , Petersen, J, Aaboe-Jørgensen, M, Hasselbalch, HC, Andersen, MH , Nielsen, SL , Fassi, DE & Schöllkopf, C 2019, 'Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy', Leukemia and Lymphoma, vol. 60, no. 13, pp. 3296-3299. https://doi.org/10.1080/10428194.2019.1633634

@article{eddc7bfcba8b43919b6b2dfd20e8d663,

title = "Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy",

author = "Holmstr{\"o}m, {Morten Orebo} and Novotny, {Guy W} and Jesper Petersen and Mia Aaboe-J{\o}rgensen and Hasselbalch, {Hans Carl} and Andersen, {Mads H} and Nielsen, {Signe Ledou} and Fassi, {Daniel El} and Claudia Sch{\"o}llkopf",

year = "2019",

month = jul,

day = "1",

doi = "10.1080/10428194.2019.1633634",

language = "English",

volume = "60",

pages = "3296--3299",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "13",

}

TY - JOUR

T1 - Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

AU - Holmström, Morten Orebo

AU - Novotny, Guy W

AU - Petersen, Jesper

AU - Aaboe-Jørgensen, Mia

AU - Hasselbalch, Hans Carl

AU - Andersen, Mads H

AU - Nielsen, Signe Ledou

AU - Fassi, Daniel El

AU - Schöllkopf, Claudia

PY - 2019/7/1

Y1 - 2019/7/1

UR - http://www.scopus.com/inward/record.url?scp=85068534944&partnerID=8YFLogxK

U2 - 10.1080/10428194.2019.1633634

DO - 10.1080/10428194.2019.1633634

M3 - Letter

C2 - 31256699

SN - 1042-8194

VL - 60

SP - 3296

EP - 3299

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 13

ER -

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Access to Document

Other files and links

Cite this